Protection of the vascular endothelium in experimental situations

Interdisciplinary Toxicology

Volumn 4, Issue 1, 2011, Pages 20-26

  Sotníková, Ružena ^a   Nedelčevová, Jana ^a   Navarová, Jana ^a   Nosálová, Viera ^a   Drábiková, Katarína ^a   Szöcs, Katalin ^a   Křenek, Peter ^b   Kyselová, Zuzana ^a   Bezek, Štefan ^a   Knezl, Vladimír ^a   Dřímal, Ján ^a   Brosková, Zuzana ^a   Kristová, Viera ^c   Okruhlicová, Ludmila ^d   Bernátová, Iveta ^d   Bauer, Viktor ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b Faculty of Natural Sciences   (Slovakia)

^c Bratislava   (Slovakia)

^d INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

diabetes; ischaemia reperfusion; pyridoindole antioxidans; SMe1EC2

Indexed keywords

ACETYLCHOLINE; ANTIOXIDANT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; GLUTATHIONE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SME1EC2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; BIOAVAILABILITY; CELL FUNCTION; CELL PROTECTION; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; EXPERIMENTAL STUDY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REVIEW; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; SUPERIOR MESENTERIC ARTERY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

RATTUS;

EID: 79955079688     PISSN: 13376853     EISSN: 13379569     Source Type: Journal    
DOI: 10.2478/v10102-011-0005-y     Document Type: Review

References (49)

1. Afanasjev I. (2010). Signaling of reactive oxygen and nitrogen species in Diabetes mellitus. Oxid Med Cell Longev 3: 361-373.
2. Babior BM. (1999). NADPH-oxidase. An update. Blood 93: 1464-1476.
3. BauerV, Sotníková R and Gergel' D. (2008). Comparison of the effects of activated neutrophils with the action of reactive oxygen species (ROS) on rat aortic smooth muscle (RASM). Prague Med Report 109: 13-14.
4. Beckman JS, Beckman TW, Chen J, Marshall PA and Freeman BA. (1990). Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1324.
5. Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G and Sessa WC. (2000). In vivo delivery of the caveolin-1 scaff olding domain inhibits nitric oxide synthesis and reduces infl ammation. Nat Med 6: 1362-1367. (Pubitemid 32001020)
6. Bucci M, Roviezzo F, Brancaleone V, Lin MI, Di Lorenzo A, Cicala C, Pinto A, Sessa WC, Farneti S, Fiorucci S and Cirino G. (2004). Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression. Atheroscler Thromb Vasc Biol 24: 721-726. (Pubitemid 38451610)
7. Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, Kuoroedov A, Gatti CD, Joch H, Volpe M and Lüscher TF. (2003). High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells. Circulation 107: 1017-1023. (Pubitemid 36258726)
8. Dai FX, Diederich A, Skopec J and Diederich D. (1993). Diabetes-induced endothelial dysfunction in styreptozotocin-treated rats: role of prostaglandin endoperoxides and free radicals. J Am Soc Nephrol 4: 1327-1336.
9. Garcia-Cardena G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, Lisanti MP and Sessa WC. (1997). Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional signifi cance of the NOS caveolin binding domain in vivo. J Biol Chem 272: 25437-25440. (Pubitemid 27438846)
10. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchov M, Thaiss F, Stahl RAK, Warnholtz A, Meinertz T, Griedling K, Harrison DG, Forstermann U and Munzel T. (2001). Mechanism underlying endothelial dysfunction in diabetes mellitus. Circ Res 88: 14-22.
11. Horáková L' and Štolc S (1998). Antioxidant and pharmacodynamic effects of pyridoindole stobadine. Gen Pharmacol 30, 627-638. (Pubitemid 28167763)
12. Karasu C, Ozansoy G, Bozkurt O, Erdoǧan D and Omeroǧlu S. (1997). Antioxidant and triglyceride-lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats. Antioxidants in Diabetes-Induced Complications (ADIC) Study Group. Metabolism 46: 872-879. (Pubitemid 27339909)
13. Lukic ML, Ejdus L, Pravica V, Shahin A, Atolic S, Mostarica M, Liew FW, Ramic Z and Badovinac V. (1998). Downregulation of Th-1 mediated autoimmune pathplogy, in Immunoregulation in Health and Disease pp. 265-278, Academic Press, London/New York.
14. Májeková M, Šnirc V, Štolc S, Májek P, Bezáková Ž and Sotníková R. (2006). The alpha1-adrenolytic and structural evaluation of new pyridoindole derivatives. Central Eur J Med 1: 370-378. (Pubitemid 44876497)
15. Maritim AC, Sanders RA and Watkins JB III. (2003). Diabetes, oxidative stress, and antioxidants: A review. J Biochem Mol Toxicol 17: 24-38. (Pubitemid 36410972)
16. Moe KT, Aulia S, Jiang F, Chua YL, Koh TH, Wong MC and Dusting GJ. (2006). Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor-á in human aortic smooth muscle and embryonic kidney cells. J Cell Mol Med 10: 231-239. (Pubitemid 44874305)
17. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K and Munzel T. (2002). Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90: 58-65.
18. Navarová J, Sotníková R and Knezl V. (1998). Effect of stobadine on lysosomal enzymes in aorta and serum of rats following ischemia and reperfusion. Èeskoslov Fysiol 47: 158 [in Slovak].
19. Nosál''ová V, Sotníková R, Drábiková K, Fialová S, Košílová D, Banšová S and Navarová J. (2010). Chemiluminescence response induced by mesenteric ischaemia/reperfusion: effect of antioxidative compounds ex vivo. Interdisc Toxicol 3: 105-108.
20. Nosál''ová V, Navarová J, Mihalová D and Sotníková R. (2007). Mesenteric ischemia/ reperfusion-induced intestinal and vascular damage: effect of stobadine. Meth Find Exp Clin Pharmacol 29: 39-45. (Pubitemid 46447222)
21. Nosál''ová V, Sotníková R, Mihalová D and Navarová J. (2004). Gut and vessel alterations induced by mesenteric ischemia/reperfusion. Central Eur J Pub Health 12: S70-S72. (Pubitemid 38568720)
22. Okruhlicová L', Weismann P, Sotníková R, Beòuška J, Štefek M, Gajdošík A and Mráz P. (2001). Effect of stobadine and arginine on the structure of diabetic aorta. Sborník lékaøský102: 315-316.
23. Shimokawa H. (1999). Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol 31: 23-37. (Pubitemid 29078216)
24. Sotníková R, Bernátová I, Nedelèevová J, Nosál''ová V and Navarová J. (2007). Vascular effects of ProvinolsTM in spontaneously hypertensive rats exposed to crowding stress, In Proceedings of Genetic and Environmental Factors in Hypertension, pp. 35-40, Institute of Normal and Pathological Physiology SAS, Bratislava.
25. Sotníková R, Drábiková K, Beòová M, Nosál''ová V, Nosál' R and Rajská P. (2005). Increased chemiluminiscence accompanies ischaemia/reperfusion-induced endothelial dysfunction of rat superior mesenteric artery. Biologia 60: S145-S147.
26. Sotníková?J, Navarová R, Dytrichová V and Kollárová M. (1997). Biochemical changes in the rat abdominal aorta induced by ischemia-reperfusion, in Drug Action on Reactive Oxygen Species with Special Attention to Stobadine. Abstracts, p.55, Institute of Experimental Pharmacology SAS, Bratislava.
27. Sotníková R, Navarová J, Kukan M and Prihelová E. (1999). Endothelial damage of the rat abdominal aorta induced by ischemia/reperfusion: Effect of antioxidants, in Abstracts from Nitric oxide-From molecular level to clinical application. Bratislava June 27-29, 1999.
28. Sotníková R, Nosál''ová V, Štolc S, Gajdošík A. and Gajdošíková A. (1999a) Streptozotocin diabetes-induced changes in aorta, peripheral nerves and stomach of Wistar rats. Gen Physiol Biophys 18: 155-162.
29. Sotníková R, Okruhlicová L' and Noskoviè P. (1998). Endothelial protective effect of stobadine on ischaemia-reperfusion- induced injury. Gen Physiol Biophys 17: 253-264.
30. Sotníková R, Okruhlicová L', Dlugošová K, Bernátová I, Bezek Š, Navarov J and Tribulová N. (2008). Effect of n-3 PUFA on endothelium-dependent relaxation of the superior mesenteric artery. Proceedings of experimental approaches in basic research and diagnostics of diseases: tailoring the treatment. (Tribulová N, Okruhlicová L', Slezík J eds) 127-134, Institute for Heart Research, Slovak Academy of Sciences and VEDA Publishing House, Bratislava.
31. Sotníková R, Poništ S, Navarová J, Mihalová D, Tomeková V, Štrosová M and Bauerová K. (2009). Effects of sesame oil in the model of adjuvant arthritis. Neuro Endocrinol Lett 30: S22-S24.
32. Sotníková R, Skalská S, Okruhlicová L', Navarová J, Kysel'ová Z, Zúrová J, Štefek M, Hozová R and Nosál''ová V. (2006a) Changes in the function and ultrastructure of vessels in the rat model of multiple low dose streptozotocininduced diabetes. Gen Physiol Biophys 25: 289-302.
33. Sotníková R, Štefek M, Okruhlicová L', Navarová J, Bauer V, Gajdošík A and Gajdoší ková A. (2001). Dietary supplementation of the pyridoindole antioxidant stobadine reduces vascular impairment in streptozotocin-diabetic rats. Meth Find Exp Clin Pharmacol 23: 121-129. (Pubitemid 32720608)
34. Sotníková R, Zúrová J and Bernátová I. (2006). Diff erences in the response of the mesenteric artery of normotensive and spontaneously hypertensive rast exposed to long-term social stress. Mechanisms and derangements of blood pressure rehulation (Bernátová I, Kristek F, Pechòová O, Török J eds) pp 61-69, Comenius University, Bratislava. [in Slovak].
35. Szöcs K, Žilka N and Sotníková R. (2003). Detection of superoxide and analysis of functional changes in the superior mesenterica artery induced by ischemia and reperfusion. Proceedings of the second Drobnica memorial, November 12-14, 2003, Senec. pp.36-37 [in Slovak].
36. Szöcs K. (2004) Endothelial dysfunction and reactive oxygen species. Production in ischemia/reperfusion and nitrate tolerance. Gen Physiol Biophys 23: 265-295. (Pubitemid 39485250)
37. Štolc S, Bauer V, Beneš L and Tichý M (1983). Czechoslovak. Patent AO-229067.
38. Štolc S, Považanec F, BauerV, Májeková M, Wilcox AL, Šnirc V, Raèková L, Sotníková R, Štefek M, Gáspárová-Kvaltínová Z, Gajdošíková A and Mihalová D. (2010). Pyridoindole derivatives with antioxidative properties, their preparation and use in therapeutic practice. Slovak, patent registration PP 287650.
39. Štolc S, Šnirc V, Májeková M, Gáspárová Z, Gajdošíková A and Štvrtina S (2006). Development of the new group of indole-derived neuroprotective drugs aff ecting oxidative stress. Cell Mol Neurobiol. 26, 1495-1504. (Pubitemid 44924062)
40. Tachi Y, Okuda Y, Bannai C, Bannai S, Shinohara M, Shimpuku H, Yamashita K and Ohura K. (2001). Hyperglycemia in diabetic rats reduces the glutathione content in the aortic tissue. Life Sci 69: 1039-1047. (Pubitemid 32701914)
41. Ujházy E, Dubovický M, Ponechalová V, Navarová J, Brucknerová I, Šnirc V and Mach M. (2008). Prenatal developmental toxicity study of the pyridoindole antioxidant SMe1EC2 in rats. Neuro Endocrinol Lett 29: 639-643.
42. Urata Y, Yamamoto H, Goto S, Tsushima H, Akazawa S, Yamashita S, Nagataki S and Kondo T. (1996). Long exposure to high glucose concentration impairs the responsive expression of gamma-glutamylcysteine synthetase by interleukin-1 beta and tumor necrosis factor-alpha in mouse endothelial cells. J Biol Chem 271: 15146-15152. (Pubitemid 26194994)
43. Vanhoutte PM and Mombouli JV. (1996). Vascular endothelium: vasoactive mediators. Prog Cardiovasc Dis 39: 229-238. (Pubitemid 26424609)
44. Waters PJ, Flyn MD, Corrall RJM and Pennock CA. (1992). Increases in plasma lysosomal enzymes in type 1 (insulin-dependent) diabetes mellitus: relationship to diabetic complications and glycaemic control. Diabetologia 35: 991-995.
45. Wendt MC, Daider A, Kleschyov AL, Mülch A, Sydow K, Schulz E, Chen K, Keaney JF, Lassegue B, Walter U, Griendling KK and Münzel T. (2005). Differential effect of diabetes on the expression of the gp91phox homologues nox1 and nox4. Free Radic Biol Med 39: 381-391. (Pubitemid 40910195)
46. Wigg SJ, Tare M, Tonta MA, O'Brien RC, Meredith IT and Parkington HC. (2001). Comparison pf effects of diabetes mellitus on an EDHF-dependent and an EDHF-independent artery. Am J Physiol Heart Circ Physiol 281: H232-H240.
47. Yan SF, Ramasamy R, Naka Y and Schmidt AM. (2003). Glycation, infl ammation, and RAGE. A scaff old for the microvasular complications of diabetes and beynod. Circ Res 93: 1159-1169.
48. Yue KKM, Lee KW, Chan KKC, Leung KSY, Leung AWN and Cheng CHK. (2006). Danshen prevents the occurrence of oxidative stress in the eye and aorta of diabetic rats without aff ecting the hyperglycemic state. J Ethnopharmacol 106: 136-141.
49. Zúrová Nedelèevová J, Navarová J, Drábiková K, Janèinová V, Petríková M, Bernátová I, Kristová V, Šnirc V, Nosál''ová V and Sotníková R. (2006). Participation of reactive oxygen species in diabetes-induced endothelial dysfunction. Neuro Endocrinol Lett 27: 68-171.